Acrivon Therapeutics, Inc. (ACRV) insider trading

Insider

Date

Role

Action

Shares

Price

Amount

Mary Miller

22 Oct 2026

Chief Legal Officer

Sell

513

$1.84

$943.92

Mary Miller

5 Oct 2026

Chief Legal Officer

Sell

294

$1.99

$585.06

Peter Blume-Jensen

25 Aug 2026

President and CEO

Sell

14,036

$2.21

$30.97K

Peter Blume-Jensen

18 Aug 2026

President and CEO

Sell indirect

484

$2.01

$972.84

Peter Blume-Jensen

18 Aug 2026

President and CEO

Sell

1,229

$2.01

$2.47K

Eric Devroe

18 Aug 2026

Chief Operating Officer

Sell

604

$2.01

$1.21K

Erick Gamelin

18 Aug 2026

Chief Development Officer

Sell

400

$2.01

$804.00

Mary Miller

18 Aug 2026

Chief Legal Officer

Sell

185

$2.01

$371.85

Katharine Peterson

18 Aug 2026

Chief Accounting Officer

Sell

101

$2.01

$203.01

Adam D. Levy

4 Aug 2026

Chief Financial Officer

Sell

1,142

$1.57

$1.79K

Mary Miller

21 Jul 2026

Chief Legal Officer

Sell

573

$1.76

$1.01K

Perceptive Advisors LLC

1 May 2025

10% owner

Sell indirect

298,886

$1.34

$400.51K

Perceptive Advisors LLC

30 Apr 2025

10% owner

Sell indirect

437,881

$1.41

$617.41K

Perceptive Advisors LLC

29 Apr 2025

10% owner

Sell indirect

250,000

$1.41

$352.50K

Perceptive Advisors LLC

28 Apr 2025

10% owner

Sell indirect

215,283

$1.56

$335.84K

Perceptive Advisors LLC

25 Apr 2025

10% owner

Sell indirect

1,054,669

$1.95

$2.06M

Chione Ltd

26 Jun 2023

10% owner

Sell

16

$12.93

$206.88

Chione Ltd

15 Jun 2023

10% owner

Sell

2,056

$12.14

$24.96K

Chione Ltd

14 Jun 2023

10% owner

Sell

893

$12.13

$10.83K

Chione Ltd

13 Jun 2023

10% owner

Sell

3,000

$12.30

$36.90K

Chione Ltd

12 Jun 2023

10% owner

Sell

2,000

$12.34

$24.68K

Acrivon Therapeutics, Inc.

What the insiders did Net buying

Individual transactions

What was left out